Dysfunctional attitudes as a moderator of pharmacotherapy and psychotherapy for chronic depression

Journal of Psychiatric Research

Volumn 47, Issue 1, 2013, Pages 113-121

  Shankman, Stewart A ^a   Campbell, Miranda L ^a   Klein, Daniel N ^b   Leon, Andrew C ^c   Arnow, Bruce A ^d   Manber, Rachel ^d   Keller, Martin B ^e   Markowitz, John C ^f   Rothbaum, Barbara O ^g   Thase, Michael E ^h   Kocsis, James H ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BROWN UNIVERSITY   (United States)

^f Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic depression; Dysfunctional attitudes; Predictor; Response; Treatment

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; SERTRALINE; VENLAFAXINE;

ADULT; ALGORITHM; ARTICLE; ATTITUDE; BRIEF SUPPORTIVE PSYCHOTHERAPY; CHRONIC DISEASE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DYSFUNCTIONAL ATTITUDE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOTHERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84869869864     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.09.018     Document Type: Article

References (66)

1. Aiken L.S., West S.G. Multiple regression: testing and interpreting interactions 1991, Sage Publications, Inc., Thousand Oaks, Ca.
2. Anderson I.M., Tomenson B.M. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal 1995, 310:1433-1438.
3. Beck A.T., Rush A.J., Shaw B.F., Emery G. Cognitive therapy of depression 1979, Guilford Press, New York, NY.
4. Beevers C.G., Wells T.T., Miller I.W. Predicting response to depression treatment: the role of negative cognition. Journal of Consulting and Clinical Psychology 2007, 75:422-431. 10.1037/0022-006X.75.3.422.
5. Blatt S.J., Quinlan D.M., Pilkonis P.A., Shea M.T. Impact of perfectionism and need for approval on the brief treatment of depression: the National Institute of Mental Health Treatment of Depression Collaborative Research Program revisited. Journal of Consulting and Clinical Psychology 1995, 63:125-132.
6. Bockting C.L.H., Spinhoven P., Koeter M.W.J., Wouters L.F., Visser L., Schene A.H. Differential predictors of response to preventative cognitive therapy in recurrent depression: a 2-year prospective study. Psychotherapy and Psychosomatics 2006, 75:229-236. 10.1159/000092893.
7. Crismon M.L., Trivedi M., Pigott T.A., Rush A.J., Hirschfeld R.M.A., Kahn D.A., et al. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. Journal of Clinical Psychiatry 1999, 142-156. 10.1097/00004583-200007000-00021.
8. de Maat S.M., Dekker J., Schoevers R.A., De Jonghe F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. European Psychiatry 2007, 22:1-8. 10.1016/j.eurpsy.2006.10.008.
9. Dobson K.S., Breiter H.J. Cognitive assessment of depression: reliability and validity of three measures. Journal of Abnormal Psychology 1983, 92:107-109. 10.1037/0021-843X.92.1.107.
10. Driessen E., Hollon S.D. Cognitive behavioral therapy for mood disorders: efficacy, moderators, and mediators. Psychiatric Clinics of North America 2010, 33:537-555.
11. Fava M., Bless E., Otto M.W., Pava J.A., Rosenbaum J.F. Dysfunctional attitudes in major depression. The Journal of Nervous and Mental Disease 1994, 182:45-49.
12. Fava M., Rush J.A., Trivedi M.H., Nierenberg A.A., Thase M.E., Sackeim H.A., et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America 2003, 26:457-494.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis-1 disorders 1995, Patient edition (SCID-I/P, Version 2.0), Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
14. Fournier J.C., DeRubeis R.J., Shelton R.C., Hollon S.D., Amsterdam J.D., Gallop R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology 2009, 77:775-787. 10.1037/a0015401.
15. Frank J. Therapeutic factors in psychotherapy. American Journal of Psychotherapy 1971, 25:350-361.
16. Gilmer W.S., Trivedi M.H., Rush A.J., Wisniewski S.R., Luther J., Howland R.H., et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatrica Scandinavica 2005, 112:425-433. 10.1111/j.1600-0047.2005.00633.x.
17. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967, 6:278-296.
18. Hamilton E.W., Abramson L.Y. Cognitive patterns and major depressive disorder: a longitudinal study in a hospital setting. Journal of Abnormal Psychology 1983, 92:173-184. 10.1037/0021-843X.92.2.173.
19. Hamilton K.E., Dobson K.S. Cognitive therapy of depression: pretreatment patient predictors of outcome. Clinical Psychology Review 2002, 22:875-894. 10.1016/S0272-7358(02)00106-X.
20. Harrison W.M., Stewart J.W. Pharmacotherapy of dysthymic disorder. Diagnosis and treatment of chronic depression 1995, 124-145. Guilford Press, New York, NY. J.H. Kocsis, D.N. Klein (Eds.).
21. Hollon S.D., Ponniah K. A review of empirically supported psychological therapies for mood disorders in adults. Depression and Anxiety 2010, 27:891-932. 10.1002/da.20741.
22. Hollon S.D., Shelton R.C., Loosen P.T. Cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology 1991, 59:88-89.
23. Hollon S.D., Thase M.E., Markowitz J.C. Treatment and prevention of depression. Psychological Science in the Public Interest 2002, 3:39-77. 10.1111/1529-1006.00008.
24. Holmbeck G.N. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. Journal of Pediatric Psychology 2002, 27:87-96. 10.1093/jpepsy/27.1.87.
25. Keller M.B., Gelenberg A.J., Hirschfeld R.M.A., Rush A.J., Thase M.E., Kocsis J.H., et al. The treatment of chronic depression, part 2: a double-blink, randomized trial of sertraline and imipramine. Journal of Clinical Psychiatry 1998, 59:598-607.
26. Keller M.B., McCullough J.P., Klein D.N., Arnow B., Dunner D.L., Gelenberg A.J., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 2000, 342:1462-1470.
27. Kendall P.C., Holmbeck G.N., Verduin T. Methodology, design, and evaluation in psychotherapy research. Handbook of psychotherapy and behavior change 2004, 16-43. Wiley, New York, NY. 5th ed. M.J. Lambert (Ed.).
28. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity, and recurrence. Journal of Affective Disorders 1993, 29:85-96. 10.1016/0165-0327(93)90026-G.
29. Klein D.F. Preventing hung juries about therapy studies. Journal of Consulting and Clinical Psychology 1996, 64:81-87.
30. Klein D.N. Classification of depressive disorders in the DSM-V: proposal for a two-dimension system. Journal of Abnormal Psychology 2008, 117:552-560. 10.1037/0021-843X.117.3.552.
31. Klein D.N. Chronic depression: diagnosis and classification. Current Directions in Psychological Science 2010, 19:96-100. 10.1177/0963721410366007.
32. Klein D.N., Taylor E.B., Harding K., Dickstein S. Double depression: comparison with episodic major depression on demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. American Journal of Psychiatry 1988, 145:1226-1231.
33. Klein D.N., Kocsis J.H., McCullough J.P., Holzer C.P., Hirschfeld R.M.A., Keller M.B. Symptomatology in dysthymic and major depressive disorder. Psychiatric Clinics of North America 1996, 19:41-55. 10.1016/S0193-953X(05)70272-0.
34. Klein D.N., Shankman S.A., Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. The American Journal of Psychiatry 2006, 163:872-880. 10.1176/appi.ajp.163.5.872.
35. Kocsis J.H., Frances A.J., Voss C., Mann J.J., Mason B.J., Sweeney J. Imipramine treatment for chronic depression. Archives of General Psychiatry 1988, 45:253-257.
36. Kocsis J.H., Gelenberg A.J., Rothbaum B.O., Klein D.N., Trivedi M.H., Manber R., et al. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP trial. Archives of General Psychiatry 2009, 66:1178-1188.
37. Kraemer H.C., Wilson G.T., Fairbern C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002, 59:877-883. 10.1001/archpsych.59.10.877.
38. Kraemer H.C., Frank E., Kupfer D.J. Moderators of treatment outcomes: clinical, research, and policy importance. Journal of the American Medical Association 2006, 296:1286-1289. 10.1001/jama.296.10.1286.
39. Ley P., Helbig-Lang S., Czilwik S., Lang T., Worlitz A., Brucher K., et al. Phenomenological differences between acute and chronic forms of major depression in inpatients. Nordic Journal of Psychiatry 2011, 65:330-337.
40. Leykin Y., Amsterdam J.D., DeRubeis R.J., Gallop R., Shelton R.C., Hollon S.D. Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of Consulting and Clinical Psychology 2007, 75:267-276.
41. Manber R., Kraemer H.C., Arnow B.A., Trivedi M., Rush A.J., Thase M.E., et al. Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. Journal of Consulting and Clinical Psychology 2008, 76:459-467.
42. Markowitz J, Sacks M. Manual for brief supportive psychotherapy. Unpublished manuscript; 2002.
43. Markowitz J.C., Manber R., Rosen P. Therapists' responses to training in brief supportive psychotherapy. American Journal of Psychotherapy 2008, 62:67-81.
44. McCullough J.P. Treatment for chronic depression: cognitive behavioral analysis system of psychotherapy 2000, Guilford Press, New York, NY.
45. McCullough J.P. Skills training manual for diagnosing and treating chronic depression: cognitive behavioral analysis system of psychotherapy 2001, Guilford Press, New York, NY.
46. McCullough J.P. Patient manual for the cognitive behavioral analysis system of psychotherapy 2002, Guilford Press, New York, NY.
47. McCullough J.P. Treatment for chronic depression using cognitive behavioral analysis system of psychotherapy (CBASP). Journal of Clinical Psychology 2003, 59:833-846. 10.1002/jclp.10176.
48. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry 2004, 61:1271-1279. 10.1001/archpsyc.61.12.1271.
49. Miller I.W., Norman W.H., Keitner G.I. Treatment response of high cognitive dysfunction depressed inpatients. Comprehensive Psychiatry 1990, 30:62-71. 10.1016/0010-440X(90)90055-W.
50. Nelson L.D., Stern S.L., Cicchetti D.V. The dysfunctional attitude scale: how well can it measure depressive thinking?. Journal of Psychopathology and Behavioral Assessment 1992, 14:217-223. 10.1007/BF00962629.
51. NIMH The National Institute of Mental Health strategic plan 2008, National Institute of Mental Health, Rockville, MD, Retrieved from. http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml.
52. Pedrelli P., Feldman G.C., Vorono S., Maurizio F., Petersen T. Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression. Psychiatry Research 2008, 161:302-308. 10.1016/j.psychres.2007.08.004.
53. Peselow E.D., Robins C.J., Block P., Barouche F., Fieve R.R. Dysfunctional attitudes in depressed patients during depression and following clinical treatment: comparison with control subjects. American Journal of Psychiatry 1990, 147:439-444.
54. Raudenbush S.W., Bryk A.S. Hierarchical linear models: applications and data analysis methods 2002, Sage Publications, Newberry Park, CA.
55. Riso L.P., du Toit P.L., Blandino J.A., Penna S., Dacey S., Duin J.S., et al. Cognitive aspects of chronic depression. Journal of Abnormal Psychology 2003, 112:72-80.
56. Rogers C.R. Client-centered therapy 1951, Houghton Mifflin, Boston, MA.
57. Satyanarayana S., Enns M.W., Cox B.J., Sareen J. Prevalence and correlates of chronic depression in the Canadian community health survey: mental health and well-being. The Canadian Journal of Psychiatry 2009, 54:389-398.
58. Simon G.E., Perlis R.H. Personalized medicine for depression: can we match patients with treatments?. American Journal of Psychiatry 2010, 167:1445-1455.
59. Simons A.D., Gordon J.S., Monroe S.M., Thase M.E. Toward an integration of psychologic, social, and biologic factors in depression: effects on outcome and course of cognitive therapy. Journal of Consulting and Clinical Psychology 1995, 63:363-377.
60. Singer J.D., Willett J.B. Applied longitudinal data analysis: modeling change and event occurrence 2003, Oxford University Press, New York, NY.
61. Sotsky S.M., Glass D.R., Shea M.T., Pilkonis P.A., Collins J.F., Elkin I., et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. The American Journal of Psychiatry 1991, 148:997-1008.
62. Thase M.E., Rush A.J. When at first you don't succeed: sequential strategies for antidepressant nonresponders. The Journal of Clinical Psychiatry 1997, 58:23-29.
63. Thase M.E., Fava M., Halbreich U., Kocsis J.H., Koran L., Davidson J., et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Archives of General Psychiatry 1996, 53:777-784.
64. Watson J.C., Gordon L.B., Stermac L., Kalogerakos F., Steckley P. Comparing the effectiveness of process-experiential with cognitive-behavioral psychotherapy in the treatment of depression. Journal of Consulting and Clinical Psychology 2003, 71:773-781. 10.1037/0022-006X.71.4.773.
65. Weissman AN, Beck AT. Development and validation of the dysfunctional attitude scale: a preliminary investigation. Paper presented at the annual meeting of the American Educational Research Association, Toronto, Ontario; 1978.
66. Williams J.M.G., Healy D., Teasdale J.D., White W., Paykel E.S. Dysfunctional attitudes and vulnerability to persistent depression. Psychological Medicine 1990, 20:375-381.